back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 10:24 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+1,857,150 vol |
2,079,372 | |
| Filed 2024-03-28 10:24 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
57 - Exercise of rights
|
+222,222 vol |
222,222 | |
| Filed 2024-03-28 10:23 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: IBI Trust Management (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 10:22 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,857,150 vol |
444,445 | |
| Filed 2024-03-28 10:22 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-222,222 vol |
2,301,595 | |
| Filed 2024-03-18 11:44 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,857,150 vol |
2,523,817 | |
| Filed 2024-03-18 11:43 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+666,667 vol |
666,667 | |
| Filed 2024-03-18 11:42 Tx date 2019-09-13 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-15 14:54 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
5,495,250 | |
| Filed 2021-09-05 05:41 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$590,000
+1,000,000 vol $0.59 each |
4,495,250 | |
| Filed 2020-06-17 08:30 Tx date 2020-06-11 |
$INNO
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
3,495,250 | |
| Filed 2019-10-06 11:05 Tx date 2019-09-25 |
$
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
+1,359,750 vol |
2,859,750 | |
| Filed 2019-10-06 03:44 Tx date 2019-09-13 |
$
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
3,095,250 | ||
| Filed 2019-09-22 17:11 Tx date 2019-09-13 |
$
InnoCan Pharma Corporation |
Bincovich, Iris Or Gabi
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,500,000 |